Circulating tumor DNA-based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.

被引：0
|
作者：
Fusco, Brendon
Tsai, Jill
Clemens, Keelia
Gulhati, Pat
机构：
[1] Rutgers Canc Inst New Jersey, Dept Hematol & Med Oncol, New Brunswick, NJ USA
[2] Guardant Hlth Inc, Redwood City, CA USA
[3] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
747
引用
收藏
页码：747 / 747
页数：1
相关论文
共 50 条
  • [41] Pancreatic ductal adenocarcinoma: the role of circulating tumor DNA
    Habib Joseph R.
    Yin Lingdi
    Yu Jun
    Faculty of Medicine
    Department of Surgery
    胰腺病学杂志（英文）, 2019, 02 (03) : 72 - 75
  • [42] Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer
    Kamatham, Saivaishnavi
    Shahjehan, Faisal
    Kasi, Pashtoon Murtaza
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [43] Utility of liquid biopsies to assess circulating tumor DNA in patients with lung adenocarcinoma.
    Schwaederle, Maria Clemence
    Patel, Sandip Pravin
    Husain, Hatim
    Ikeda, Megumi
    Lanman, Richard Burnham
    Banks, Kimberly C.
    Talasaz, AmirAli
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Clinical validity of electric field induced release and measurement (EFIRM) for KRAS mutation detection in circulating DNA associated with pancreatic ductal adenocarcinoma.
    Wong, David T.
    Tang, Jason Hieu
    Kwon, Wooil
    Park, Moonsoo
    Wang, Xiaoqian
    Kaczor-Urbanowicz, Karolina
    Tu, Michael
    Wei, Fang
    Heo, Jin-Seok
    Chia, David
    Kim, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Identification of an optimal circulating tumor DNA (ctDNA) shedding threshold to detect actionable driver mutations in colorectal and pancreatic adenocarcinoma.
    Caughey, Bennett Adam
    Umemoto, Kumiko
    Green, Michelle
    Ikeda, Masafumi
    D'Anna, Rachel
    Ueno, Makoto
    Niedzwiecki, Donna
    Taniguchi, Hiroya
    Walden, Daniel
    Komatsu, Yoshito
    Zhou, Katherine I.
    Esaki, Taito
    Ramaker, Ryne
    Denda, Tadamichi
    Datto, Michael
    Bando, Hideaki
    Bekaii-Saab, Tanios S.
    Yoshino, Takayuki
    Strickler, John H.
    Nakamura, Yoshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Feasibility and clinical value of circulating tumor DNA testing in patients with gastroesophageal adenocarcinoma.
    Iqbal, Madiha
    Kasi, Pashtoon Murtaza
    Mody, Kabir
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Brain metastasis are more frequent in EGFR mutated than in wild-type lung adenocarcinoma.
    Fernandes Amarante, Marcus Paulo
    D'Alpino, Renata D'Alpino
    Gomes, Jessica Ribeiro
    Moreira, Raphael Brandao
    Soares de Sousa, Tercia Tarciane
    Kawamura, Carolina
    De Sousa Cruz, Marcelo Rocha
    Maluf, Fernando C.
    Buzaid, Antonio C.
    De Sa Barreto Costa, Marcos Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Clinical utility of advanced features provided by circulating tumor DNA-based comprehensive genomic profiling
    Kim, Y-G.
    Ha, C.
    Lim, S. H.
    Hong, J. Y.
    Kim, S. T.
    Sun, J-M.
    Lee, J.
    Kim, J-W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1625 - S1625
  • [49] Characterizing the genomic landscape of bladder cancer with circulating tumor DNA
    Vandekerkhove, Gillian R.
    Todenhofer, Tilman
    Annala, Matti
    Struss, Werner J.
    Beja, Kevin
    Wong, Amanda
    North, Scott
    Eigl, Bernie
    Black, Peter
    Wyatt, Alexander W.
    CANCER RESEARCH, 2017, 77
  • [50] KRAS Wild-Type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential
    Kato, Hiroyuki
    Ellis, Haley
    Bardeesy, Nabeel
    CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4527 - 4529
12345